An internal standard for the quantification of esmolol
Related Products
Unlabeled Version(s)
22581Esmolol (hydrochloride)
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Esmolol-d7 (hydrochloride)

Item No. 30727

Technical Information
Formal Name
methyl 3-(4-(2-hydroxy-3-((propan-2-yl-d7)amino)propoxy)phenyl)propanoate, monohydrochloride
CAS Number
1346598-13-7
Molecular Formula
C16H18D7NO4 • HCl
Formula Weight
Purity
≥99% deuterated forms (d1-d7)
Formulation
A solid
Methanol: soluble
SMILES
OC(COC1=CC=C(CCC(OC)=O)C=C1)CNC(C([2H])([2H])[2H])([2H])C([2H])([2H])[2H].Cl
InChi Code
InChI=1S/C16H25NO4.ClH/c1-12(2)17-10-14(18)11-21-15-7-4-13(5-8-15)6-9-16(19)20-3;/h4-5,7-8,12,14,17-18H,6,9-11H2,1-3H3;1H/i1D3,2D3,12D;
InChi Key
GEKNCWBANDDJJL-ODLOEXKQSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Esmolol-d7 is intended for use as an internal standard for the quantification of esmolol (Item No. 22581) by GC- or LC-MS. Esmolol is a β1-adrenergic receptor (β1-AR) antagonist.1 It binds to β1-ARs (Kd = 100 nM in isolated cardiac myocytes) and is 34-fold selective for β1- over β2-ARs.1,2 Esmolol also inhibits L-type Ca2+ currents (ICa.L) and the fast Na+ current (INa) in rat cardiac myocytes (IC50s = 50 and 169 μM, respectively), which results in complete ventricular arrest at concentrations greater than or equal to 1 mM.1 Formulations containing esmolol have been used in the treatment of cardiac arrhythmias, postoperative hypertension, and acute ischemic heart disease, as well as to minimize myocardial contraction during cardiac surgery and attenuate the adrenergic response associated with tracheal intubation.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Fallouh, H.B., Bardswell, S.C., McLatchie, L.M., et alEsmolol cardioplegia: The cellular mechanism of diastolic arrest. Cardiovasc. Res. 87(3), 552-560 (2010).

    2. Jahn, P., Eckrich, B., Schneidrowski, B., et alβ1-adrenoceptor subtype selective antagonism of esmolol and its major metabolite in vitro and in man. Investigations using tricresylphosphate as red blood cell carboxylesterase inhibitor. Arzneimittelforschung 45(5), 536-541 (1995).